Interestingly, several studies have posited FN1 and ITGA3 as potential autonomous prognostic biomarkers for various diseases, including ovarian cancer, pancreatic cancer, oral squamous cell carcinoma, and breast cancer [33,41,42]. This evidence concerns the gene FN1 and familial pancreatic carcinoma.